Russell Investments Group, Ltd. Pliant Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 529 shares of PLRX stock, worth $7,601. This represents 0.0% of its overall portfolio holdings.

Number of Shares

529

Previous 344 53.78%

Holding current value

$7,601

Previous $3,000 66.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.52 - $14.35 $1,946 - $2,654	185 Added 53.78%	529 $5,000
Q2 2024 Aug 08, 2024	SELL	$10.58 - $15.61 $489,536 - $722,274	-46,270 Reduced 99.26%	344 $3,000
Q1 2024 May 08, 2024	SELL	$14.14 - $19.59 $189,292 - $262,251	-13,387 Reduced 22.31%	46,614 $694,000
Q4 2023 Feb 05, 2024	SELL	$12.85 - $19.15 $600,609 - $895,070	-46,740 Reduced 43.79%	60,001 $1.09 Million
Q3 2023 Nov 13, 2023	BUY	$14.58 - $20.15 $147,841 - $204,321	10,140 Added 10.5%	106,741 $1.85 Million
Q2 2023 Aug 10, 2023	SELL	$18.12 - $30.56 $1.5 Million - $2.53 Million	-82,703 Reduced 46.12%	96,601 $1.75 Million
Q1 2023 May 09, 2023	SELL	$18.73 - $36.26 $69,394 - $134,343	-3,705 Reduced 2.02%	179,304 $4.77 Million
Q4 2022 Feb 08, 2023	SELL	$17.0 - $25.43 $144,126 - $215,595	-8,478 Reduced 4.43%	183,009 $3.54 Million
Q3 2022 Nov 04, 2022	BUY	$7.67 - $24.23 $1.25 Million - $3.95 Million	163,008 Added 572.38%	191,487 $4 Million
Q2 2022 Jul 29, 2022	SELL	$4.11 - $8.75 $505,579 - $1.08 Million	-123,012 Reduced 81.2%	28,479 $227,000
Q1 2022 May 05, 2022	BUY	$7.01 - $14.1 $837,260 - $1.68 Million	119,438 Added 372.63%	151,491 $1.06 Million
Q4 2021 Jan 21, 2022	BUY	$12.27 - $18.26 $35,227 - $52,424	2,871 Added 9.84%	32,053 $431,000
Q2 2021 Aug 04, 2021	BUY	$28.05 - $37.69 $818,555 - $1.1 Million	29,182 New	29,182 $848,000

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $700M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Pliant Therapeutics, Inc. Transaction History